Alnylam Pharmaceuticals (ALNY) Change in Receivables (2009 - 2026)
Alnylam Pharmaceuticals posted quarterly Change in Receivables of $110.4 million for Q1 2026, up 1385.35% year-on-year from $7.4 million in Q1 2025, and up 159.93% on a QoQ basis from -$184.2 million in Q4 2025.
Alnylam Pharmaceuticals (ALNY) has 18 years of Change in Receivables data on file, last reported at $110.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 1385.35% year-over-year to $110.4 million; the trailing twelve-month figure through Mar 2026 stood at $463.0 million (up 390.44% YoY), and the FY2025 full-year result was $360.0 million, up 315.9% from the prior year.
- Change in Receivables for Q1 2026 stood at $110.4 million, up from -$184.2 million in the prior quarter.
- Across five years, Change in Receivables topped out at $399.9 million in Q3 2025 and bottomed at -$184.2 million in Q4 2025.
- The 5-year median for Change in Receivables is $7.4 million (2025), against an average of $40.6 million.
- The widest annual swing landed in 2022, when Change in Receivables slumped 470.68%; it then jumped 1913.17% in 2025.
- A 5-year view of Change in Receivables shows it stood at $53.3 million in 2022, then sank by 107.26% to -$3.9 million in 2023, then surged by 1638.07% to $59.5 million in 2024, then tumbled by 409.62% to -$184.2 million in 2025, then surged by 159.93% to $110.4 million in 2026.
- The last three Change in Receivables figures came in at $110.4 million (Q1 2026), -$184.2 million (Q4 2025), and $399.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.42 Mn |
| Mar 31, 2026 | 110.42 Mn |
| Dec 31, 2025 | -184.25 Mn |
| Dec 31, 2025 | -184.25 Mn |
| Sep 30, 2025 | 399.86 Mn |
| Sep 30, 2025 | 399.86 Mn |
| Jun 30, 2025 | 136.91 Mn |
| Jun 30, 2025 | 136.91 Mn |
| Mar 31, 2025 | 7.43 Mn |
| Mar 31, 2025 | 7.43 Mn |
| Dec 31, 2024 | 59.51 Mn |
| Dec 31, 2024 | 59.51 Mn |
| Sep 30, 2024 | 37.09 Mn |
| Sep 30, 2024 | 37.09 Mn |
| Jun 30, 2024 | -9.64 Mn |
| Jun 30, 2024 | -9.64 Mn |
| Mar 31, 2024 | -410,000.00 |
| Mar 31, 2024 | -410,000.00 |
| Dec 31, 2023 | -3.87 Mn |
| Dec 31, 2023 | -3.87 Mn |
| Sep 30, 2023 | 107.99 Mn |
| Sep 30, 2023 | 107.99 Mn |
| Jun 30, 2023 | 2.97 Mn |
| Jun 30, 2023 | 2.97 Mn |
| Mar 31, 2023 | -19.15 Mn |
| Mar 31, 2023 | -19.15 Mn |
| Dec 31, 2022 | 53.27 Mn |
| Dec 31, 2022 | 53.27 Mn |
| Sep 30, 2022 | 38.42 Mn |
| Sep 30, 2022 | 38.42 Mn |
| Jun 30, 2022 | -6.40 Mn |
| Jun 30, 2022 | -6.40 Mn |
| Mar 31, 2022 | -39.70 Mn |
| Mar 31, 2022 | -39.70 Mn |
| Dec 31, 2021 | 59.45 Mn |
| Dec 31, 2021 | 59.45 Mn |
| Sep 30, 2021 | -3.67 Mn |
| Sep 30, 2021 | -3.67 Mn |
| Jun 30, 2021 | 35.31 Mn |
| Jun 30, 2021 | 35.31 Mn |
| Mar 31, 2021 | 10.71 Mn |
| Mar 31, 2021 | 10.71 Mn |
| Dec 31, 2020 | 21.17 Mn |
| Dec 31, 2020 | 21.17 Mn |
| Sep 30, 2020 | 8.97 Mn |
| Sep 30, 2020 | 8.97 Mn |
| Jun 30, 2020 | -6.78 Mn |
| Jun 30, 2020 | -6.78 Mn |
| Mar 31, 2020 | 32.88 Mn |
| Mar 31, 2020 | 32.88 Mn |
| Dec 31, 2019 | -5.48 Mn |
| Dec 31, 2019 | -5.48 Mn |
| Sep 30, 2019 | 17.78 Mn |
| Sep 30, 2019 | 17.78 Mn |
| Jun 30, 2019 | -3.11 Mn |
| Jun 30, 2019 | -3.11 Mn |
| Mar 31, 2019 | 15.04 Mn |
| Mar 31, 2019 | 15.04 Mn |
| Dec 31, 2018 | 15.40 Mn |
| Dec 31, 2018 | 15.40 Mn |
| Sep 30, 2018 | 401,000.00 |
| Sep 30, 2018 | 401,000.00 |
| Jun 30, 2018 | -47.81 Mn |
| Jun 30, 2018 | -47.81 Mn |
| Mar 31, 2018 | 16.77 Mn |
| Mar 31, 2018 | 16.77 Mn |
| Dec 31, 2017 | 19.36 Mn |
| Dec 31, 2017 | 19.36 Mn |
| Sep 30, 2017 | -761,000.00 |
| Sep 30, 2017 | -761,000.00 |
| Jun 30, 2017 | -4.05 Mn |
| Jun 30, 2017 | -4.05 Mn |
| Mar 31, 2017 | -3.88 Mn |
| Mar 31, 2017 | -3.88 Mn |
| Dec 31, 2016 | 8.19 Mn |
| Dec 31, 2016 | 8.19 Mn |
| Sep 30, 2016 | 5.63 Mn |
| Sep 30, 2016 | 5.63 Mn |
| Jun 30, 2016 | 700,000.00 |
| Jun 30, 2016 | 700,000.00 |
| Mar 31, 2016 | 516,000.00 |
| Mar 31, 2016 | 516,000.00 |
| Dec 31, 2015 | 168,000.00 |
| Dec 31, 2015 | 168,000.00 |
| Sep 30, 2015 | -1.27 Mn |
| Sep 30, 2015 | -1.27 Mn |
| Jun 30, 2015 | -704,000.00 |
| Jun 30, 2015 | -704,000.00 |
| Mar 31, 2015 | -29.83 Mn |
| Mar 31, 2015 | -29.83 Mn |
| Dec 31, 2014 | 39.55 Mn |
| Dec 31, 2014 | 39.55 Mn |
| Sep 30, 2014 | 295,000.00 |
| Sep 30, 2014 | 295,000.00 |
| Jun 30, 2014 | -75,000.00 |
| Jun 30, 2014 | -75,000.00 |
| Mar 31, 2014 | -4.08 Mn |
| Mar 31, 2014 | -4.08 Mn |
| Dec 31, 2013 | 3.64 Mn |
| Dec 31, 2013 | 3.64 Mn |
| Sep 30, 2013 | 149,000.00 |
| Sep 30, 2013 | 149,000.00 |
| Jun 30, 2013 | -98,000.00 |
| Jun 30, 2013 | -98,000.00 |
| Mar 31, 2013 | 454,000.00 |
| Mar 31, 2013 | 454,000.00 |
| Dec 31, 2012 | -1.81 Mn |
| Dec 31, 2012 | -1.81 Mn |
| Sep 30, 2012 | -2.47 Mn |
| Sep 30, 2012 | -2.47 Mn |
| Jun 30, 2012 | 2.19 Mn |
| Jun 30, 2012 | 2.19 Mn |
| Mar 31, 2012 | 724,000.00 |
| Mar 31, 2012 | 724,000.00 |
| Dec 31, 2011 | -559,000.00 |
| Dec 31, 2011 | -559,000.00 |
| Sep 30, 2011 | 719,000.00 |
| Sep 30, 2011 | 719,000.00 |
| Jun 30, 2011 | 158,000.00 |
| Jun 30, 2011 | 158,000.00 |
| Mar 31, 2011 | -2.30 Mn |
| Mar 31, 2011 | -2.30 Mn |
| Dec 31, 2010 | -1.43 Mn |
| Dec 31, 2010 | -1.43 Mn |
| Sep 30, 2010 | -1.48 Mn |
| Sep 30, 2010 | -1.48 Mn |
| Jun 30, 2010 | 1.85 Mn |
| Jun 30, 2010 | 1.85 Mn |
| Mar 31, 2010 | -1.54 Mn |
| Mar 31, 2010 | -1.54 Mn |
| Dec 31, 2009 | 1.02 Mn |
| Dec 31, 2009 | 1.02 Mn |
| Sep 30, 2009 | -835,000.00 |
| Sep 30, 2009 | -835,000.00 |